Education
About Us
Working with TipRanks
Follow Us
Iradimed Corp (IRMD)
NASDAQ:IRMD
IRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$40.18 - $63.29
Previous CloseN/A
Volume15.52K
Average Volume (3M)42.30K
Market Cap
$683.23M
Enterprise Value$591.17M
Total Cash (Recent Filing)$28.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)35.9
Beta0.77
Next Earnings
May 01, 2025EPS Estimate
0.41Last Dividend Ex-Date
Feb 24, 2025Dividend Yield1.15%
Share Statistics
EPS (TTM)1.50
Shares Outstanding12,673,441
10 Day Avg. Volume40,191
30 Day Avg. Volume42,298
Standard Deviation0.10
R-Squared0.16
Alpha0.00952
Financial Highlights & Ratios
PEG Ratio3.19
Price to Book (P/B)N/A
Price to Sales (P/S)9.58
Price to Cash Flow (P/CF)18.70
P/FCF Ratio33.50
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.79
Enterprise Value/Ebitda25.96
Forecast
1Y Price Target
$71.00Price Target Upside33.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Iradimed News
PremiumCompany Announcements
Iradimed Corp: Record Revenue and Positive Outlook
PremiumCompany Announcements
IRADIMED CORPORATION Reports Record Revenue Growth
PremiumPre-Earnings
Is IRMD a Buy, Before Earnings?
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRMD FAQ
What was Iradimed Corp’s price range in the past 12 months?
Iradimed Corp lowest stock price was $40.18 and its highest was $63.29 in the past 12 months.
What is Iradimed Corp’s market cap?
Iradimed Corp’s market cap is $683.23M.
When is Iradimed Corp’s upcoming earnings report date?
Iradimed Corp’s upcoming earnings report date is May 01, 2025 which is in 58 days.
How were Iradimed Corp’s earnings last quarter?
Iradimed Corp released its earnings results on Feb 13, 2025. The company reported $0.44 earnings per share for the quarter, the consensus estimate of $0.44 by $0.
Is Iradimed Corp overvalued?
According to Wall Street analysts Iradimed Corp’s price is currently Undervalued.
Does Iradimed Corp pay dividends?
Iradimed Corp pays a Thriceyearly dividend of $0.17 which represents an annual dividend yield of 1.15%. See more information on Iradimed Corp dividends here
What is Iradimed Corp’s EPS estimate?
Iradimed Corp’s EPS estimate is 0.41.
How many shares outstanding does Iradimed Corp have?
Iradimed Corp has 12,673,441 shares outstanding.
What happened to Iradimed Corp’s price movement after its last earnings report?
Iradimed Corp reported an EPS of $0.44 in its last earnings report, expectations of $0.44. Following the earnings report the stock price went down -8.391%.
Which hedge fund is a major shareholder of Iradimed Corp?
Currently, no hedge funds are holding shares in IRMD
---
Iradimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.00 (33.23% Upside)
$71.00 (33.23% Upside)
Hedge Fund Trend
Decreased
By 11.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $135.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.89%
12-Months-Change
Fundamentals
Return on Equity
24.31%
Trailing 12-Months
Asset Growth
6.69%
Trailing 12-Months
Company Description
Iradimed Corp
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
---
IRMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with record-breaking revenue and growth, strong domestic sales, and increased earnings per share, despite challenges in international sales, a slight decline in gross margin, and impacts from capital expenditures.Read More>---
IRMD Stock 12 Month Forecast
Average Price Target
$71.00
▲(33.23% Upside)
Technical Analysis
Baxter International
―
Bio-Rad Laboratories
―
Hologic
―
Stryker
―
Zimmer Biomet Holdings
―
Best Analysts Covering IRMD
1 Year
1 Year Success Rate
8/12 ratings generated profit
1 Year Average Return
+11.41%
reiterated a buy rating 19 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +11.41% per trade.
---